It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ionotropic gelation is widely used to fabricate targeting nanoparticles (NPs) with polysaccharides, leveraging their recognition by specific lectins. Despite the fabrication scheme simply involves self-assembly of differently charged components in a straightforward manner, the identification of a potent combinatory formulation is usually limited by structural diversity in compound collections and trivial screen process, imposing crucial challenges for efficient formulation design and optimization. Herein, we report a diversity-oriented combinatory formulation screen scheme to identify potent gene delivery cargo in the context of precision cardiac therapy. Distinct categories of cationic compounds are tested to construct RNA delivery system with an ionic polysaccharide framework, utilizing a high-throughput microfluidics workstation coupled with streamlined NPs characterization system in an automatic, step-wise manner. Sequential computational aided interpretation provides insights in formulation optimization in a broader scenario, highlighting the usefulness of compound library diversity. As a result, the out-of-bag NPs, termed as GluCARDIA NPs, are utilized for loading therapeutic RNA to ameliorate cardiac reperfusion damages and promote the long-term prognosis. Overall, this work presents a generalizable formulation design strategy for polysaccharides, offering design principles for combinatory formulation screen and insights for efficient formulation identification and optimization.
In this work, the authors use a high-throughput automatic microfluidics workstation to present a generalizable formulation design strategy for developing polysaccharide-based nanosystem for siRNA delivery.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 University Medical Center Groningen (UMCG), The Personalized Medicine Research Institute (PRECISION), University of Groningen, Department of Biomaterials and Biomedical Technology, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Helsinki, Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
2 Zhejiang University School of Medicine, Department of Vascular Surgery, The Second Affiliated Hospital, Hangzhou, China (GRID:grid.412465.0)
3 Chinese Academy of Sciences, Shanghai Institute of Ceramics, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309)
4 Southeast University, Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489)
5 Tel Aviv University, Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Tel Aviv University, Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Tel Aviv University, Center for Nanoscience and Nanotechnology, Tel Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Tel Aviv University, Cancer Biology Research Center, Tel Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)
6 Zhejiang University School of Medicine, Department of Orthopedic Surgery, The Second Affiliated Hospital, Hangzhou, China (GRID:grid.412465.0)